Cencora, Inc. (0HF3.L)
| Previous close | 240.53 |
| Open | 239.12 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 238.24 - 240.80 |
| 52-week range | 150.19 - 240.80 |
| Volume | |
| Avg. volume | 775 |
| Market cap | 500.652M |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 0.29 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
CONSHOHOCKEN, Pa., April 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024.
- Business Wire
Cencora Announces Leadership Succession Plan
CONSHOHOCKEN, Pa., March 12, 2024--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date.
- Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.
